Improving the Performance of Specialty Pharmacists in the Care of Patients With Pulmonary Arterial Hypertension
James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan
At the completion of this activity, the participant will be able to:
- Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
- Identify patients hwho are at high risk for major bleeding secondary to DOAC use
- Examine current and emerging DOAC reversal agents and their safety and efficacy
- Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignetttes.
TARGET AUDIENCE: Health-system pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: March 15, 2019
EXPIRATION DATE: March 15, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.